Belite Bio, Inc (BLTE) Misses Q2 EPS by 3c

Belite Bio, Inc (NASDAQ: BLTE) reported Q2 EPS of ($0.26), $0.03 worse than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Belite Bio, Inc (BLTE) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters
• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat